Showing results (241-250 of 496) with videos related to
Sort By:
Pageof 50
The Oncologist|August 14, 2020
PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCAEmily N Risdon, Cindy H Chau, Douglas K Price, et al.Journal of Clinical Gastroenterology|June 1, 1990
Common variable hypogammaglobulinemia. A case reportD Ruttenberg, S R Ress, S K Price, et al.Oncology Reports|February 9, 2006
Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasisArun S Singh, Gordon R Macpherson, Douglas K Price, et al.Mutation Research|February 15, 2011
The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivityRui Gao, Kelie Reece, Tristan Sissung, et al.Pharmacological Research|November 7, 2016
Androgen receptor variation affects prostate cancer progression and drug resistanceEdel McCrea, Tristan M Sissung, Douglas K Price, et al.Clinical Genitourinary Cancer|October 23, 2012
Bcl-2 family of proteins as therapeutic targets in genitourinary neoplasmsConnor Hall, Sarah M Troutman, Douglas K Price, et al.British Medical Journal|January 1, 1972
Brain amine concentrations after monoamine oxidase inhibitor administrationA B Jones, C M Pare, W J Nicholson, et al.Annals of the Royal College of Surgeons of England|September 3, 2024
Immobilisation in a collar and cuff with high elbow flexion is a safe and effective treatment option to reduce and immobilise Gartland type II supracondylar fracturesR Y Yap, L Bommireddy, A Firth, et al.Genes|August 26, 2023
The Transmission Patterns of the Endosymbiont <i>Wolbachia</i> within the Hawaiian Drosophilidae Adaptive RadiationRenée L Corpuz, M Renee Bellinger, Anne Veillet, et al.Investigational New Drugs|July 9, 2002
Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancerWilliam D Figg, Erwin A Kruger, Douglas K Price, et al.Pageof 50